Description
BSE announces changes to the Short Term 5/15/30 Days ASM Framework effective March 05, 2026, including 3 new securities added, 1 moved to a higher stage, and 10 securities exiting the framework.
Summary
BSE has issued the updated applicability list for the Short Term Additional Surveillance Measure (ST-ASM) framework under the 5/15/30 Days ASM structure, effective March 05, 2026. Three new securities have been shortlisted for inclusion, one security is being elevated to a higher ASM stage, no securities are being moved to a lower stage, and ten securities are exiting the ST-ASM framework (some transitioning to LT-ASM or ESM frameworks).
Key Points
- 3 new securities added to ST-ASM framework (Stage I) effective March 05, 2026
- 1 security (Yajur Fibres Ltd, SME scrip) moved to a higher ASM stage
- NIL securities moved to a lower ASM stage
- 10 securities exiting ST-ASM framework, with reasons including transition to LT-ASM, ESM framework, or standard exit
- SME scrips are specifically identified with the
@marker - One security (Integrated Proteins Ltd) exiting due to inclusion in LT-ASM; one (Zelio E Mobility Ltd) also moving to LT-ASM
- Two securities (Lippi Systems Ltd, Akme Fintrade India Ltd) exiting due to inclusion in ESM framework
Regulatory Changes
Newly Shortlisted in ST-ASM (Annexure I – Part A):
| Scrip Code | ISIN | Scrip Name |
|---|---|---|
| 512441 | INE993I01029 | Enbee Trade & Finance Ltd |
| 530439 | INE140C01012 | Siddha Ventures Ltd |
| 539561 | INE549S01036 | Supha Pharmachem Ltd |
Moving to Higher ST-ASM Stage:
| Scrip Code | ISIN | Scrip Name |
|---|---|---|
| 544676 | INE0CNJ01010 | Yajur Fibres Ltd (SME) |
Moving to Lower ST-ASM Stage: NIL
Exiting ST-ASM Framework (Annexure II – Part A):
| Scrip Code | ISIN | Scrip Name | Reason |
|---|---|---|---|
| 535916 | INE030P01017 | Alacrity Securities Ltd | Standard exit |
| 542865 | INE490Z01012 | Anuroop Packaging Ltd | Standard exit |
| 512573 | INE871C01038 | Avanti Feeds Ltd | Standard exit |
| 500672 | INE234A01025 | Novartis India Ltd | Standard exit |
| 543958 | INE03HW01020 | VL E-Governance & IT Solutions Ltd | Standard exit |
| 543594 | INE0MC401013 | Dipna Pharmachem Ltd (SME) | Standard exit |
| 519606 | INE177M01013 | Integrated Proteins Ltd | Moving to LT-ASM |
| 544563 | INE1B3501014 | Zelio E Mobility Ltd (SME) | Moving to LT-ASM |
| 526604 | INE845B01018 | Lippi Systems Ltd | Moving to ESM |
| 544200 | INE916Y01027 | Akme Fintrade (India) Ltd | Moving to ESM |
Compliance Requirements
- Brokers and trading members must apply revised margin and surveillance conditions for the 3 newly added securities from March 05, 2026
- Clients holding positions in newly added securities should be aware of enhanced surveillance margins under the ST-ASM framework
- Securities moving to higher ASM stages face stricter trading restrictions; brokers must ensure compliance with the applicable stage requirements for Yajur Fibres Ltd
- For securities exiting ST-ASM into LT-ASM or ESM, the respective framework conditions (Long Term ASM or Enhanced Surveillance Measure) will now apply
- NSE data is used as reference for securities marked with
*
Important Dates
- Effective Date: March 05, 2026 — all changes (inclusions, stage movements, and exits) come into effect
- Circular Date: March 04, 2026
Impact Assessment
This circular has a high immediate impact on traders and investors in the affected scrips. The three newly included securities (Enbee Trade & Finance, Siddha Ventures, Supha Pharmachem) will be subject to additional surveillance margins, reducing leverage and increasing cost of trading. Yajur Fibres Ltd (SME) faces tighter restrictions due to elevation to a higher ASM stage. The 10 exiting securities will see normalized trading conditions unless they are transitioning to stricter frameworks (LT-ASM for Integrated Proteins and Zelio E Mobility; ESM for Lippi Systems and Akme Fintrade), which carry equal or greater restrictions. Investors in Novartis India Ltd and Avanti Feeds Ltd — larger, more widely held companies — benefit from their removal from surveillance restrictions.
Impact Justification
Directly affects trading conditions for 14 securities across inclusion, stage movement, and exit categories; traders and investors in these scrips face immediate margin and trading restrictions from March 05, 2026.